Onyinye Echeumuna, NP
NPI: 1629484456
Total Payments
$1,763
2024 Payments
$513.25
Companies
14
Transactions
55
Medicare Patients
1,099
Medicare Billing
$67,569
Payment Breakdown by Category
Food & Beverage$1,747 (99.1%)
Other$16.05 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,747 | 54 | 99.1% |
| Debt forgiveness | $16.05 | 1 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $429.35 | 15 | $0 (2024) |
| Abbott Laboratories | $385.00 | 6 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $304.50 | 7 | $0 (2024) |
| Novo Nordisk Inc | $176.64 | 10 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $103.09 | 5 | $0 (2024) |
| Kyowa Kirin, Inc. | $94.52 | 1 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $67.39 | 1 | $0 (2023) |
| ABIOMED | $62.72 | 2 | $0 (2024) |
| Astellas Pharma US Inc | $53.65 | 3 | $0 (2023) |
| Phathom Pharmaceuticals, Inc. | $20.82 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $513.25 | 20 | ABBVIE INC. ($153.30) |
| 2023 | $750.61 | 25 | Abbott Laboratories ($246.98) |
| 2022 | $499.43 | 10 | AstraZeneca Pharmaceuticals LP ($215.00) |
All Payment Transactions
55 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/07/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Diabetes | ||||||
| 11/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $37.36 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/02/2024 | Kyowa Kirin, Inc. | — | Food and Beverage | In-kind items and services | $94.52 | General |
| 09/17/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $25.36 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Respiratory | ||||||
| 08/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.16 | General |
| Category: Diabetes | ||||||
| 07/11/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $23.43 | General |
| 07/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $30.76 | General |
| Category: NEUROSCIENCE | ||||||
| 05/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: NEUROSCIENCE | ||||||
| 05/22/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: Respiratory | ||||||
| 04/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: NEUROSCIENCE | ||||||
| 04/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.79 | General |
| Category: Obesity | ||||||
| 03/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: NEUROSCIENCE | ||||||
| 03/01/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: Obesity | ||||||
| 02/14/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: Diabetes | ||||||
| 02/09/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $26.47 | General |
| Category: NEUROSCIENCE | ||||||
| 02/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $26.91 | General |
| Category: Respiratory | ||||||
| 01/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: Obesity | ||||||
| 11/08/2023 | E.R. Squibb & Sons, L.L.C. | ONUREG (Drug) | Food and Beverage | Cash or cash equivalent | $67.39 | General |
| Category: Oncology | ||||||
| 11/08/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: DIABETES | ||||||
| 10/18/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $34.45 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $15.10 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 226 | 356 | $41,703 | $17,981 |
| 2022 | 4 | 204 | 332 | $31,688 | $13,950 |
| 2021 | 9 | 340 | 516 | $46,315 | $18,637 |
| 2020 | 7 | 329 | 509 | $43,675 | $17,001 |
Total Patients
1,099
Total Services
1,713
Medicare Billing
$67,569
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 97 | 177 | $26,373 | $12,461 | 47.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 62 | 83 | $8,300 | $3,306 | 39.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 15 | 15 | $2,895 | $1,137 | 39.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 37 | 65 | $3,575 | $618.80 | 17.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 15 | 16 | $560.00 | $458.08 | 81.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 121 | 218 | $21,800 | $10,508 | 48.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 39 | 44 | $6,556 | $2,875 | 43.8% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 30 | 56 | $3,080 | $536.50 | 17.4% |
| 81003 | Automated urinalysis test | Office | 2022 | 14 | 14 | $252.00 | $31.15 | 12.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 167 | 300 | $30,000 | $13,151 | 43.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 44 | 50 | $7,450 | $3,244 | 43.5% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 51 | 87 | $4,785 | $837.38 | 17.5% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 12 | 12 | $1,788 | $576.64 | 32.3% |
| 90756 | Vaccine for influenza derived from cell cultures for injection into muscle, quadrivalent, antibiotic free, 0.5ml dosage | Office | 2021 | 15 | 15 | $825.00 | $424.88 | 51.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 15 | 15 | $525.00 | $237.49 | 45.2% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2021 | 12 | 12 | $324.00 | $74.76 | 23.1% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2021 | 12 | 12 | $384.00 | $62.16 | 16.2% |
| 81003 | Automated urinalysis test | Office | 2021 | 12 | 13 | $234.00 | $29.25 | 12.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 182 | 331 | $33,100 | $13,232 | 40.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 19 | 21 | $3,129 | $1,257 | 40.2% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 17 | 17 | $1,060 | $716.43 | 67.6% |
| 90756 | Vaccine for influenza for injection into muscle | Office | 2020 | 25 | 25 | $1,375 | $692.50 | 50.4% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 44 | 68 | $3,740 | $657.05 | 17.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 25 | 25 | $875.00 | $396.75 | 45.3% |
| 81003 | Automated urinalysis test | Office | 2020 | 17 | 22 | $396.00 | $49.35 | 12.5% |
About Onyinye Echeumuna, NP
Onyinye Echeumuna, NP is a Student in an Organized Health Care Education/Training Program healthcare provider based in Katy, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/01/2014. The National Provider Identifier (NPI) number assigned to this provider is 1629484456.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Onyinye Echeumuna, NP has received a total of $1,763 in payments from pharmaceutical and medical device companies, with $513.25 received in 2024. These payments were reported across 55 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,747).
As a Medicare-enrolled provider, Echeumuna has provided services to 1,099 Medicare beneficiaries, totaling 1,713 services with total Medicare billing of $67,569. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Family
- Location Katy, TX
- Active Since 07/01/2014
- Last Updated 02/13/2025
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1629484456
Products in Payments
- VRAYLAR (Drug) $396.48
- FREESTYLE LIBRE 3 (Device) $246.98
- BREZTRI (Drug) $125.00
- GVOKE HYPOPEN (Drug) $103.09
- FREESTYLE LIBRE (Device) $99.18
- ONUREG (Drug) $67.39
- AIRSUPRA (Drug) $66.07
- Impella (Device) $62.72
- Veozah (Drug) $53.65
- Wegovy (Drug) $52.29
- FREESTYLE LIBRE 2 (Device) $38.84
- Rybelsus (Drug) $36.13
- QULIPTA (Drug) $32.87
- VOQUEZNA (Drug) $20.82
- Ozempic (Drug) $20.33
- MOUNJARO (Drug) $18.16
- TRADJENTA (Drug) $16.26
- Cologuard Collection Kit (Device) $15.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Katy
James Showery, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $25,338
Student in an Organized Health Care Education/Training Program $25,338
Oforbuike Ewelukwa, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $3,725
Student in an Organized Health Care Education/Training Program $3,725
Erin Bolivar, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $3,552
Student in an Organized Health Care Education/Training Program $3,552
Tiffany Ikwuagwu, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $3,466
Student in an Organized Health Care Education/Training Program $3,466
Stephanie Roy, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $3,163
Student in an Organized Health Care Education/Training Program $3,163
Christian Ibanez
Student in an Organized Health Care Education/Training Program — Payments: $2,563
Student in an Organized Health Care Education/Training Program $2,563